90%
profits
reinvest
+20%
targets growth
annually
20+
new products
annually
600+
registration
certificates
41+
operate in countries
around the world
25%
is part of the
exports
The only top-5 Ukrainian pharmaceutical company built from scratch
R&D
Adaptation,
development and scaling of technologies for
the production of biopharmaceutical API's and drugs based
on them
Development of
products based on hyaluronic acid
Development of Active
Pharmaceutical Ingredients
Development and
implementation in manufacturing of
hospital drugs and medical devices
MANUFACTURING
Ukraine
PRODUCTION LINES -
41
PRODUCTION AREAS -
25,000 m2
PRODUCTION CAPACITY -
over 290 million units per year
Italy (Diaco)
PRODUCTION LINES -
7
PRODUCTION AREAS -
3,000 m2
PRODUCTION CAPACITY -
over 33 million units per year
MARKETING
Market share: 3.3%*
Hospital distributor
No. 3 in Ukraine (7.8% market share)**
Share in parenteral
drugs: 13,4%*
In 5 years doubled our
share in the market of consumed parenteral drugs
No. 3 in turnover
among domestic and foreign pharmaceutical companies*
DISTRIBUTION (Medical Center "M.T.K.")
To be closer to our
customers, we have created our own distribution service
Total area of storage
facilities in Ukraine: 33,000 m²
Thousands of tons of
products are sent from warehouses across Ukraine to
consumers every day
Strategy 2020-2030
To become one of the world's top 100 pharmaceutical companies by implementing the mission. The basis of the long-term strategy is the "INTERNATIONAL PRODUCT" - a product that is in demand, competitive and available outside of Ukraine.
Quality
The quality management system is built in such a way as to
ensure
the manufacture of a consistently high-quality, safe and
effective
pharmaceutical product that meets the needs of the end user
and
international regulatory requirements.
